Pharmacologic Options for Treatment and Prevention of Hypertensive Disorders of Pregnancy
Clinics in Perinatology · 2026-09 · 53 (3) · 465-480
DOI: 10.1016/j.clp.2026.04.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinics in Perinatology, 2026-09. Verfasst von E Nicole Teal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Diego. Electronic ad…. Hauptthemen laut MEDLINE: Antihypertensive Agents, Hypertension, Pregnancy-Induced. Die Arbeit nennt 82 Literaturangaben. Gefördert von: National Institutes of Health.
Abstract (Originalsprache)
Hypertensive disorders affect 15% of US pregnancies, significantly contributing to maternal and neonatal morbidity. This paper explores the profound hemodynamic adaptations of pregnancy and how their failure leads to conditions like preeclampsia and gestational hypertension. Diagnosis relies on blood pressure thresholds (≥140/90 mm Hg), with management focusing on preventing severe sequelae. Labetalol and nifedipine are established as first-line treatments due to their safety and efficacy, while angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are strictly contraindicated due to fetotoxicity. Low-dose aspirin is recommended for high-risk patients. Ultimately, early recognition and evidence-based pharmacologic intervention are critical for improving obstetric outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Diego. Electronic address: enteal@health.ucsd.edu.
- Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Diego.
- Department of Obstetrics and Gynecology, University of Iowa and University of South Florida.
Förderung
- National Institutes of Health
Zitieren
APA
Teal, E. N., Katlaps, I., & Yankowitz, J. (2026). Pharmacologic Options for Treatment and Prevention of Hypertensive Disorders of Pregnancy. Clinics in Perinatology, 53(3), 465-480. https://doi.org/10.1016/j.clp.2026.04.002
Vancouver
Teal EN, Katlaps I, Yankowitz J. Pharmacologic Options for Treatment and Prevention of Hypertensive Disorders of Pregnancy. Clinics in Perinatology. 2026;53(3):465-480. doi:10.1016/j.clp.2026.04.002
BibTeX
@article{Teal2026,
author = {Teal, E Nicole and Katlaps, Isabel and Yankowitz, Jerome},
title = {Pharmacologic Options for Treatment and Prevention of Hypertensive Disorders of Pregnancy},
journal = {Clinics in Perinatology},
year = {2026},
volume = {53},
number = {3},
pages = {465--480},
doi = {10.1016/j.clp.2026.04.002}
}
EUVIMED